The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons
Open accessAbstract
Hyperphosphorylated tau is the major component of paired helical filaments in neurofibrillary lesions associated with Alzheimer's disease. Hyperphosphorylation reduces the affinity of tau for microtubules and is thought to be a critical event in the pathogenesis of this disease. Recently, glycogen-synthase kinase-3 has been shown to phosphorylate tau in vitro and in non-neuronal cells transfected with tau. The activity of glycogen-synthase kinase-3 can be down-regulated in response to insulin or insulin-like growth factor-1 through the activation of the phosphatidylinositol 3-kinase pathway. We therefore hypothesize that insulin or insulin-like growth factor-1 may affect tau phosphorylation through the inhibition of glycogen-synthase kinase-3 in neurons. Using cultured human neuronal NT2N cells, we demonstrate that glycogen-synthase kinase-3 phosphorylates tau and reduces its affinity for microtubules and that insulin and insulin-like growth factor-1 stimulation reduces tau phosphorylation and promotes tau binding to microtubules. We further demonstrate that these effects of insulin and insulin-like growth factor-1 are mediated through the inhibition of glycogen-synthase kinase-3 via the phosphatidylinositol 3-kinase/protein kinase B signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,240
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
The distribution of tau in the mammalian central nervous system.
Binder, L. I., Frankfurter, A., & Rebhun, L. I. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.4.1371 · Cited by 1,588
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Self-citationMolecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,112
Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau.
Drechsel, D. N., Hyman, A. A., Cobb, M. H., & Kirschner, M. W. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.10.1141 · Cited by 970
Sutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903
Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Self-citationDrewes, G., Ebneth, A., Preuss, U., Mandelkow, E.-M., & Mandelkow, E. (1997) · Cell · doi:10.1016/s0092-8674(00)80208-1 · Cited by 878
Biernat, J., Gustke, N., Drewes, G., Mandelkow, E., & Mandelkow, E. (1993) · Neuron · doi:10.1016/0896-6273(93)90279-z · Cited by 796
Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., & Anderton, B. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90774-2 · Cited by 737
Greenberg, S. G., & Davies, P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5827 · Cited by 730
Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
Powis, G., Bonjouklian, R., Berggren, M. M., Gallegos, A. C., Abraham, R. T., Ashendel, C. L., Zalkow, L. H., Matter, W. F., Dodge, J. A., & Grindey, G. B. (1994) · PubMed · Cited by 687
Identification of normal and pathological aging in prospectively studied nondemented elderly humans
Dickson, D. W., Crystal, H. A., Mattiace, L. A., Masur, D. M., Blau, A. D., Davies, P., Yen, S.-H., & Aronson, M. K. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90027-u · Cited by 643
Pleasure, S., Page, C., & Lee, V. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01802.1992 · Cited by 608
Self-citationRapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase
Kuo, C. J., Chung, J., Fiorentino, D. F., Flanagan, W. M., Blenis, J., & Crabtree, G. R. (1992) · Nature · doi:10.1038/358070a0 · Cited by 595
Matsuo, E. S., Shin, R.-W., Billingsley, M. L., Van deVoorde, A., O'Connor, M., Trojanowski, J. Q., & Lee, V. M. Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90264-x · Cited by 576
Self-citationMitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state.
Drewes, G., Lichtenberg‐Kraag, B., Döring, F., Mandelkow, E. M., Biernat, J., Goris, J., Dorée, M., & Mandelkow, E. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05272.x · Cited by 565
Vallee, R. B. (1982) · The Journal of cell biology · doi:10.1083/jcb.92.2.435 · Cited by 551
Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau
Mandelkow, E.-M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J. R., & Mandelkow, E. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81496-9 · Cited by 515
Epitopes that span the tau molecule are shared with paired helical filaments
Kosik, K. S., Orecchio, L. D., Binder, L., Trojanowski, J. Q., Lee, V. M.-Y., & Lee, G. (1988) · Neuron · doi:10.1016/0896-6273(88)90129-8 · Cited by 497
Self-citationAbnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5
Baumann, K., Mandelkow, E.-M., Biernat, J., Piwnica-Worms, H., & Mandelkow, E. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80849-p · Cited by 478
Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J.-M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., et al. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00246-3 · Cited by 469
Pleasure, S. J., & Lee, V. M. ‐. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350603 · Cited by 437
Self-citationIshiguro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida, T., & Imahori, K. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81066-9 · Cited by 402
Sontag, E., Nunbhakdi-Craig, V., Lee, G., Bloom, G. S., & Mumby, M. C. (1996) · Neuron · doi:10.1016/s0896-6273(00)80250-0 · Cited by 391
Goedert, M., Jakes, R., Crowther, R. A., Cohen, P., Vanmechelen, E., Vandermeeren, M., & Cras, P. (1994) · Biochemical Journal · doi:10.1042/bj3010871 · Cited by 375
Increasing cAMP attenuates activation of mitogen-activated protein kinase.
Sevetson, B. R., Kong, X., & Lawrence, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10305 · Cited by 371
Neuritic pathology and dementia in alzheimer's disease
McKee, A. C., Kosik, K. S., & Kowall, N. W. (1991) · Annals of Neurology · doi:10.1002/ana.410300206 · Cited by 358
Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau
Seubert, P., Mawal-Dewan, M., Barbour, R., Jakes, R., Goedert, M., Johnson, G. V. W., Litersky, J. M., Schenk, D., Lieberburg, I., Trojanowski, J. Q., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18917 · Cited by 345
Self-citationDistribution of tau proteins in the normal human central and peripheral nervous system.
Trojanowski, J. Q., Schuck, T., Schmidt, M. L., & Lee, V. M. (1989) · Journal of Histochemistry & Cytochemistry · doi:10.1177/37.2.2492045 · Cited by 329
Self-citationThe Insulin-Like Growth Factor-I Receptor
De Meyts, P., Wallach, B., Christoffersen, C. T., Ursø, B., Grønskov, K., Latus, L.-J., Yakushiji, F., Ilondo, M., & Shymko, R. M. (1994) · Hormone Research · doi:10.1159/000184188 · Cited by 320
Goedert, M., Cohen, E. S., Jakes, R., & Cohen, P. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81418-l · Cited by 272
Wagner, U., Utton, M., Gallo, J.-M., & Miller, C. C. J. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.6.1537 · Cited by 254
Lee, V., & Andrews, P. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-02-00514.1986 · Cited by 241
Self-citationSutherland, C., & Cohen, P. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80112-6 · Cited by 238
Kobayashi, S., Ishiguro, K., Omori, A., Takamatsu, M., Arioka, M., Imahori, K., & Uchida, T. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80723-8 · Cited by 234
Yoshida, H., & Ihara, Y. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03642.x · Cited by 231
Haselbacher, G. K., Schwab, M. E., Pasi, A., & Humbel, R. E. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2153 · Cited by 205
Glycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cells
Sperbera, B. R., Leight, S., Goedert, M., & Lee, V. M.-Y. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11902-9 · Cited by 204
Self-citationSzendrei, G. I., Lee, V. M. ‐., & Otvos, L. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490340212 · Cited by 200
Self-citationMill, J. F., Chao, M. V., & Ishii, D. N. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7126 · Cited by 176
Recio-Pinto, E., Lang, F. F., & Ishii, D. N. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.8.2562 · Cited by 166
Litersky, J. M., Johnson, G. V. W., Jakes, R., Goedert, M., Michael, L. E. E., & Seubert, P. A. (1996) · Biochemical Journal · doi:10.1042/bj3160655 · Cited by 165
Saka, V. R., Hall, K., Holtz, H. V., Humbel, R., Sjören, B., & Wetterberg, L. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90089-1 · Cited by 164
Welsh, G. I., WILSON, C. G., & Proud, C. G. (1996) · Trends in Cell Biology · doi:10.1016/0962-8924(96)10023-4 · Cited by 149
Fujisawa, Y., Sasaki, K., & Akiyama, K. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90158-i · Cited by 123
Bramblett, G. T., Trojanowski, J. Q., & Lee, V. M. (1992) · PubMed · Cited by 115
Self-citationPumiglia, K. M., Lau, L., Huang, C., Burroughs, S. F., & Feinstein, M. B. (1992) · Biochemical Journal · doi:10.1042/bj2860441 · Cited by 114
Desensitization of brain insulin receptor Effect on glucose/energy and related metabolism
Hoyer, S., Müller, D., & Plaschke, K. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9350-1_20 · Cited by 104
Merrick, S. E., Demoise, D. C., & Lee, V. M. ‐. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5589 · Cited by 83
Self-citationLatimer, D. A., Gallo, J.-M., Lovestone, S., Miller, C. C. J., Hugh Reynolds, C., Marquardt, B., Stabel, S., Woodgett, J. R., & Anderton, B. H. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00434-b · Cited by 48
Marks, J. L., King, M. G., & Baskin, D. G. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5949-4_41 · Cited by 47
Heidenreich, K. A., & TOLEDO, S. P. (1989) · Endocrinology · doi:10.1210/endo-125-3-1458 · Cited by 47
Cited by
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Self-citationSteen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
“Moreover, the increased levels of phosphotau that are generally detected in AD brains could reflect impaired insulin/IGF-I signaling with attendant increased levels of GSK-3 β activity, since GSK-3β is one of the major kinases responsible for hyper-phosphorylating tau [46].”
BackgroundDiabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258
“Insulin has also been hypothesized to regulate phosphorylation.(37,38) Finally, other potential mechanisms include the production of advanced glycation end products(39) or alterations of oxidative stress pathways, calcium homeostasis, and hippocampal synaptic plasticity.”
BackgroundPI3K/Akt and apoptosis: size matters
Franke, T. F., Hornik, C. P., Segev, L., Shostak, G. A., & Sugimoto, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207115 · Cited by 1,184
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Metadata
- Authors
- Hong, M., & Lee, V. M.-Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-08
- Volume
- 272
- Issue
- 31
- Pages
- 19547-19553
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2031472414
- Cited by
- 522
- References
- 61
- FWCI
- 10.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.